Lumantam, Jonathan C.
HRN: 28 36 18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/02/2026
01/09/2026
IV
500MG
Q8H
Acute Appendicitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes